Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor
- PMID: 1348449
Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor
Abstract
To investigate whether overexpression of the neu protein in breast tumors differentiates risk factor patterns for breast cancer, neu protein overexpression was determined in 296 breast carcinomas of patients participating in an ongoing population-based case-control study. Risk factor information on these patients and 737 controls was obtained during home interviews. Most breast cancer risk factors showed similar associations with neu-positive and neu-negative tumors, but remarkable differences were found for breast-feeding and age at first full-term pregnancy. In contrast to the slightly protective effect of breast-feeding in the neu-negative group, the risk of neu-positive breast cancer was 4.2-fold increased in women who ever breast-fed. Increasing age at first full-term pregnancy was positively associated with both neu-positive and neu-negative breast cancer, but the association was about 2 times stronger for neu-positive tumors. We conclude that neu oncogene overexpression of the breast tumor seems to be associated with a distinct risk factor pattern.
Similar articles
-
Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.Cancer Res. 1993 Oct 15;53(20):4960-70. Cancer Res. 1993. PMID: 8104689
-
Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):413-9. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10350436
-
Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.Cancer Res. 1991 Jan 15;51(2):556-67. Cancer Res. 1991. PMID: 1670762
-
The role of the HER-2/neu oncogene in gynecologic cancers.J Soc Gynecol Investig. 1996 May-Jun;3(3):99-105. J Soc Gynecol Investig. 1996. PMID: 8796816 Review.
-
Neu (C-erbB-2) oncogene in breast cancer and its possible association with the risk of distant metastases. A retrospective study and review of literature.Acta Oncol. 1990;29(7):931-4. doi: 10.3109/02841869009096392. Acta Oncol. 1990. PMID: 1979748 Review.
Cited by
-
The protective effect of parity in hormone receptor-positive, Ki-67 expressing breast cancer.World J Surg. 2014 May;38(5):1065-9. doi: 10.1007/s00268-014-2468-4. World J Surg. 2014. PMID: 24481994
-
Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status.BMC Womens Health. 2005 Feb 4;5(1):1. doi: 10.1186/1472-6874-5-1. BMC Womens Health. 2005. PMID: 15694000 Free PMC article.
-
Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.Oncogene. 2006 Jun 1;25(23):3325-34. doi: 10.1038/sj.onc.1209365. Epub 2006 Jan 23. Oncogene. 2006. PMID: 16434967 Free PMC article.
-
The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology.Breast Cancer Res Treat. 1995 Jul;35(1):51-60. doi: 10.1007/BF00694745. Breast Cancer Res Treat. 1995. PMID: 7612904
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous